These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25041028)

  • 1. Could targeting secretory leukocyte protease inhibitor be an effective therapeutic option to prevent infections in acute liver failure?
    Possamai LA; Khamri W; Triantafyllou E; Wendon JA; Thursz MR; Antoniades CG
    Immunotherapy; 2014; 6(6):667-9. PubMed ID: 25041028
    [No Abstract]   [Full Text] [Related]  

  • 2. Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response.
    Majchrzak-Gorecka M; Majewski P; Grygier B; Murzyn K; Cichy J
    Cytokine Growth Factor Rev; 2016 Apr; 28():79-93. PubMed ID: 26718149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure.
    Triantafyllou E; Pop OT; Possamai LA; Wilhelm A; Liaskou E; Singanayagam A; Bernsmeier C; Khamri W; Petts G; Dargue R; Davies SP; Tickle J; Yuksel M; Patel VC; Abeles RD; Stamataki Z; Curbishley SM; Ma Y; Wilson ID; Coen M; Woollard KJ; Quaglia A; Wendon J; Thursz MR; Adams DH; Weston CJ; Antoniades CG
    Gut; 2018 Feb; 67(2):333-347. PubMed ID: 28450389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure.
    Antoniades CG; Khamri W; Abeles RD; Taams LS; Triantafyllou E; Possamai LA; Bernsmeier C; Mitry RR; O'Brien A; Gilroy D; Goldin R; Heneghan M; Heaton N; Jassem W; Bernal W; Vergani D; Ma Y; Quaglia A; Wendon J; Thursz M
    Hepatology; 2014 Apr; 59(4):1564-76. PubMed ID: 24282114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity.
    Sallenave JM
    Am J Respir Cell Mol Biol; 2010 Jun; 42(6):635-43. PubMed ID: 20395631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Gingerol ameliorates sepsis-induced liver injury through the Nrf2 pathway.
    Hong MK; Hu LL; Zhang YX; Xu YL; Liu XY; He PK; Jia YH
    Int Immunopharmacol; 2020 Mar; 80():106196. PubMed ID: 31978803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paralysed monocytes in acute on chronic liver disease.
    Antoniades CG; Wendon J; Vergani D
    J Hepatol; 2005 Feb; 42(2):163-5. PubMed ID: 15664238
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of secretory leucoprotease inhibitor in the resolution of inflammatory responses.
    Weldon S; McGarry N; Taggart CC; McElvaney NG
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):273-6. PubMed ID: 17371258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation.
    Klimenkova O; Ellerbeck W; Klimiankou M; Ünalan M; Kandabarau S; Gigina A; Hussein K; Zeidler C; Welte K; Skokowa J
    Blood; 2014 Feb; 123(8):1239-49. PubMed ID: 24352879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
    Gehrke N; Hövelmeyer N; Waisman A; Straub BK; Weinmann-Menke J; Wörns MA; Galle PR; Schattenberg JM
    J Hepatol; 2018 May; 68(5):986-995. PubMed ID: 29366909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of secretory leukocyte protease inhibitor after spinal cord injury.
    Ghasemlou N; Bouhy D; Yang J; López-Vales R; Haber M; Thuraisingam T; He G; Radzioch D; Ding A; David S
    Brain; 2010 Jan; 133(Pt 1):126-38. PubMed ID: 20047904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma and allergy: An IFNγ bias in severe asthma.
    Leavy O
    Nat Rev Immunol; 2015 Aug; 15(8):466-7. PubMed ID: 26184713
    [No Abstract]   [Full Text] [Related]  

  • 13. The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells.
    Simpkins FA; Devoogdt NM; Rasool N; Tchabo NE; Alejandro EU; Kamrava MM; Kohn EC
    Carcinogenesis; 2008 Mar; 29(3):466-72. PubMed ID: 17916899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated concentration of secretory leukocyte protease inhibitor in the cervical mucus before delivery.
    Samejima T; Nagamatsu T; Schust DJ; Itaoka N; Iriyama T; Nakayama T; Komatsu A; Kawana K; Osuga Y; Fujii T
    Am J Obstet Gynecol; 2016 Jun; 214(6):741.e1-7. PubMed ID: 26778384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation and characterization of monoclonal antibodies against human secretory leukocyte protease inhibitor].
    Chen YZ; He SH; Zhou YC; Huang T; Liu YN; Chen LF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):54-7. PubMed ID: 16388746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
    Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
    J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract.
    Huppert JS; Huang B; Chen C; Dawood HY; Fichorova RN
    J Infect Dis; 2013 May; 207(9):1462-70. PubMed ID: 23355743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection.
    Lange A; Cajander S; Magnuson A; Sundén-Cullberg J; Strålin K; Hultgren O
    Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1425-1434. PubMed ID: 31089838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short communication: Increased expression of secretory leukocyte protease inhibitor in oral mucosa of Colombian HIV type 1-exposed seronegative individuals.
    Taborda N; Zapata-Builes W; Montoya C; Rugeles MT
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1059-62. PubMed ID: 22149181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis.
    Wasmuth HE; Kunz D; Yagmur E; Timmer-Stranghöner A; Vidacek D; Siewert E; Bach J; Geier A; Purucker EA; Gressner AM; Matern S; Lammert F
    J Hepatol; 2005 Feb; 42(2):195-201. PubMed ID: 15664244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.